Guangdong Transtek Medicl Elctrncs CoLtd (300562) Stock Price & News

(CNY)	Sep 2024	Y/Y change
Revenue	257.74M	15.37%
Operating expense	72.53M	5.01%
Net income	15.68M	139.39%
Net profit margin	6.08	107.51%
Earnings per share	—	—
EBITDA	26.69M	266.97%
Effective tax rate	1.39%	—

Balance Sheet

Total assets

Total liabilities

(CNY)	Sep 2024	Y/Y change
Cash and short-term investments	691.06M	-2.94%
Total assets	1.55B	-3.04%
Total liabilities	538.22M	-9.00%
Total equity	1.02B	—
Shares outstanding	216.59M	—
Price to book	3.15	—
Return on assets	3.41%	—
Return on capital	4.53%	—

Cash Flow

Net change in cash

(CNY)	Sep 2024	Y/Y change
Net income	15.68M	139.39%
Cash from operations	41.85M	-34.93%
Cash from investing	-365.91M	-192.46%
Cash from financing	-44.17M	-171.82%
Net change in cash	-367.00M	-2,251,453.26%
Free cash flow	-11.68M	-130.92%

About

Transtek Medical, commonly known as Lifesense, fully referred to as Guangdong Transtek Medical Electronics Co., Ltd., is a Chinese wearable device maker that also focuses on the field of mobile health. The company was founded by Weichao Pan in 2002, with its main products being home medical and health electronics, such as scales, smart bracelets and blood pressure monitors. According to IDC, the company shipped one million units of wearables in the second quarter of 2016, ranking fifth in the global wearable devices market, coming in behind Fitbit, Apple and Garmin. Transtek's IPO application was approved by the CSRC in October 2016. On November 16, it landed on the Shenzhen Stock Exchange with the ticker symbol "300562.SZ". Wikipedia

Founded

Jul 18, 2002

Website

lifesense.com

Employees

1,286